• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

EoE Management: Timely Diagnosis and Multifaceted Treatment Goals

Opinion
Video

Mirna Chehade, MD, MPH, outlines consequences that can stem from delay in diagnosis of eosinophilic esophagitis (EoE), as well as treatment goals, highlighting unique considerations for treatment in children.

This is a video synopsis/summary of an Insights involving Mirna Chehade, MD, MPH.

Chehade addresses the consequences of delayed eosinophilic esophagitis (EoE) diagnosis, emphasizing potential complications. These include persistent symptoms, higher risk of severe esophageal food impaction requiring urgent intervention, remodeling of the esophagus leading to stiffness, narrowing, or structure formation, and an increasing burden on patients and their families, both physically and psychosocially.

In response to treatment goals for EoE in pediatric and older patients, Chehade outlines several objectives. These include inducing and maintaining disease remission, preventing or reversing complications like failure to thrive (reversible with successful treatment), and minimizing adverse effects. For pediatric patients, the focus is on social and psychological aspects, taking into consideration the impact of feeding difficulties and highly restrictive diets on their quality of life. Chehade emphasizes the importance of involving dietitians and feeding therapists, monitoring long-term adverse effects of pharmacological therapies, and finding a balance between efficacy and quality of life in treatment approaches. This comprehensive overview highlights the multifaceted goals of EoE management across different age groups.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.

Related Videos
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
"Integrating New PAH Therapies into Clinical Practice"
"Clinical Evidence for Emerging PAH Therapies"
Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.